These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2422013

  • 1. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ, van Nagell JR, Nelson K, Gallion H, Donaldson ES, Kenady DE, Baranowska-Kortylewicz J.
    Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
    [Abstract] [Full Text] [Related]

  • 2. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Gallion H, Kenady DE.
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [Abstract] [Full Text] [Related]

  • 3. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Hanson MB, Gallion H, Flanigan RC, Kenady DE.
    Biochemistry; 1985 Dec 31; 24(27):8101-6. PubMed ID: 4092059
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 31; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 5. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ, Jordan VC.
    Endocrinology; 1980 Dec 31; 107(6):2011-20. PubMed ID: 7191796
    [Abstract] [Full Text] [Related]

  • 6. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF.
    Cancer Res; 1984 Jan 31; 44(1):112-9. PubMed ID: 6537799
    [Abstract] [Full Text] [Related]

  • 7. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK, Ruh MF, Butler WB, Ruh TS.
    Endocrinology; 1986 Mar 31; 118(3):1087-95. PubMed ID: 3948766
    [Abstract] [Full Text] [Related]

  • 8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 31; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
    Reed CA, Berndtson AK, Nephew KP.
    Anticancer Drugs; 2005 Jun 31; 16(5):559-67. PubMed ID: 15846122
    [Abstract] [Full Text] [Related]

  • 10. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
    Singh RK, Ruh MF, Ruh TS.
    J Steroid Biochem; 1984 Aug 31; 21(2):205-8. PubMed ID: 6482431
    [Abstract] [Full Text] [Related]

  • 11. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL, Ruh MF, Ruh TS.
    J Steroid Biochem; 1984 Dec 31; 21(6):625-31. PubMed ID: 6527530
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ, Nelson K, Srinivasan S, Powell DE, Kenady DE, DePriest PD, Gallion HH, van Nagell JR.
    Cancer Res; 1992 Aug 01; 52(15):4106-12. PubMed ID: 1638522
    [Abstract] [Full Text] [Related]

  • 14. 4-Hydroxytamoxifen inhibits K(+) currents in mouse ventricular myocytes.
    El Gebeily G, Fiset C.
    Eur J Pharmacol; 2010 Mar 10; 629(1-3):96-103. PubMed ID: 20006599
    [Abstract] [Full Text] [Related]

  • 15. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M, Greene G, Rochefort H, Jensen EV.
    Endocrinology; 1982 Apr 10; 110(4):1355-61. PubMed ID: 7060530
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen.
    Sasson S, Notides AC.
    Mol Endocrinol; 1988 Apr 10; 2(4):307-12. PubMed ID: 3380103
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
    Attardi B.
    J Recept Res; 1984 Apr 10; 4(7):787-800. PubMed ID: 6527361
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
    Müller RE, Traish AM, Wotiz HH.
    Endocrinology; 1985 Nov 10; 117(5):1839-47. PubMed ID: 4042965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.